Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

Clinical trial NCT07167446 · RECRUITING

Trial details

NCT number: NCT07167446
Sponsor: Fox Chase Cancer Center
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients Metastatic Colorectal Cancer (CRC)Peripheral Neuropathy Due to Chemotherapy

Start date: 2025-10-14
Primary completion: 2027-09-05
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.